NCT04196738

Brief Summary

The aim of the COMIX-R study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

June 30, 2020

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2022

Completed
Last Updated

January 9, 2024

Status Verified

January 1, 2024

Enrollment Period

2.3 years

First QC Date

November 12, 2019

Last Update Submit

January 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • change of PaO2 (mmHg)

    Arterial partial pressure of dioxygen Of note: As it is a physiological study, all the primary and secondary outcomes will be analyzed with the same importance.

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

Secondary Outcomes (13)

  • -Respiratory rate variability

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

  • -expiratory and inspiratory transpulmonary pressure

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

  • -ventilation distribution in the lungs

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

  • -other arterial parameters of hematosis

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

  • -Work of breathing (WOB)

    15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes

  • +8 more secondary outcomes

Study Arms (2)

Dual Mode first

EXPERIMENTAL

Four consecutive steps (45 min per step) in the following order: APRV (A), Dual Mode (B) , APRV (A) and VAC (C). (ABAC)

Other: ventilation strategy

VAC fist

EXPERIMENTAL

Four consecutive steps (45 min per step) in the following order: APRV (A), VAC (C) , APRV (A) and Dual Mode (B). (ACAB)

Other: ventilation strategy

Interventions

Patients are ventilated in randomised order with three different ventilation strategies: volume assist control (constant flow), Dual Mode or Airway Pressure Released Ventilation

Dual Mode firstVAC fist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Invasive mechanical ventilation on tracheal probe
  • Acute respiratory distress syndrome, as defined by Berlin conference consensus, during hospitalization in intensive care,
  • Recovery phase of acute respiratory distress syndrome: spontaneous ventilation representing from 20 to 30% of ventilation in APRV mode.
  • No severe acidosis (pH\> 7.30)
  • Patient affiliated to or beneficiary of a health care plan
  • Express consent of the patient or his/her SDM

You may not qualify if:

  • Pneumothorax
  • Contraindication to the insertion of a nasogastric tube with an esophageal balloon
  • Contraindication to the use of Electrical impedance tomography (pacemaker)
  • Pregnancy, lactating or parturient woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital

Angers, 49100, France

Location

Study Officials

  • Francois BELONCLE, CCU-AH

    Angers teatching hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: patients exposed to 3 ventilatory mode in 2 different possible orders
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2019

First Posted

December 12, 2019

Study Start

June 30, 2020

Primary Completion

October 26, 2022

Study Completion

October 26, 2022

Last Updated

January 9, 2024

Record last verified: 2024-01

Locations